G

Graft Polymer UK PLC
LSE:GPL

Watchlist Manager
Graft Polymer UK PLC
LSE:GPL
Watchlist
Price: 0.165 GBX -5.71% Market Closed
Market Cap: £3.8m

Operating Margin

-489.9%
Current
Improving
by 21.7%
vs 3-y average of -511.6%

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-489.9%
=
Operating Income
£-1.7m
/
Revenue
£347k

Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.

Operating Margin
-489.9%
=
Operating Income
GBX-1.7m
/
Revenue
£347k

Peer Comparison

Country Company Market Cap Operating
Margin
UK
Graft Polymer UK PLC
LSE:GPL
3.8m GBP
Loading...
US
Sherwin-Williams Co
NYSE:SHW
85.9B USD
Loading...
US
Ecolab Inc
NYSE:ECL
79.9B USD
Loading...
JP
Shin-Etsu Chemical Co Ltd
TSE:4063
10.5T JPY
Loading...
CN
Wanhua Chemical Group Co Ltd
SSE:600309
263.7B CNY
Loading...
CH
Givaudan SA
SIX:GIVN
29B CHF
Loading...
IN
Asian Paints Ltd
NSE:ASIANPAINT
2.6T INR
Loading...
DK
Novozymes A/S
CSE:NZYM B
165.6B DKK
Loading...
US
PPG Industries Inc
NYSE:PPG
25B USD
Loading...
CH
Sika AG
F:SIKA
19.9B EUR
Loading...
US
Albemarle Corp
NYSE:ALB
22.4B USD
Loading...

Market Distribution

Lower than 98% of companies in United Kingdom
Percentile
2st
Based on 3 579 companies
2st percentile
-489.9%
Low
-195 650% — 0%
Typical Range
0% — 0.2%
High
0.2% — 4 630.7%
Distribution Statistics
United Kingdom
Min -195 650%
30th Percentile 0%
Median 0.1%
70th Percentile 0.2%
Max 4 630.7%

Graft Polymer UK PLC
Glance View

Market Cap
3.8m GBX
Industry
Chemicals

Graft Polymer (UK) Ltd. is a holding company, which comprises polymer modification and drug delivery systems developments. The firm's primary business comprises polymer modification and drug delivery systems developments. The company develops range of products, including grafted polymer modifiers; nano-structured and crosslinking polymer alloys; and a variety of delivery vehicles for pharma and bio applications. Its products fall into the category of standard products, such as Polypropylene-based composites, Polyamide-based composites, and other composites; custom made products; and innovative products, such as GRAFTALLOY, GRAFTAKIT, GRAFTAMER TRC, and GRAFTAMER VTR. The firm provides three main types of modification solutions, including Graft/Block copolymers, Polymeric Nano-Structured Alloys and Crosslinking Master batches.

GPL Intrinsic Value
Not Available
What is Operating Margin?
Operating Margin shows how much profit a company makes from its regular business activities after covering operating costs. It helps measure how efficiently the company turns sales into profit.
How is Operating Margin calculated?

Operating Margin is calculated by dividing the Operating Income by the Revenue.

Operating Margin
-489.9%
=
Operating Income
£-1.7m
/
Revenue
£347k
What is Graft Polymer UK PLC's current Operating Margin?

The current Operating Margin for Graft Polymer UK PLC is -489.9%, which is above its 3-year median of -511.6%.

How has Operating Margin changed over time?

Over the last 1 years, Graft Polymer UK PLC’s Operating Margin has increased from -668.3% to -489.9%. During this period, it reached a low of -668.3% on May 30, 2023 and a high of -376.5% on Dec 31, 2023.

Back to Top